Seasonal temperatures in South Eleuthera, The Bahamas, have considerable impacts on the cardiorespiratory function and swimming performance of Nassau grouper (Epinephelus striatus).

Surprisingly, the impacts of environmental changes on the physiology of tropical/subtropical marine fishes have received limited attention. Given that (i) temperature is considered to be a key factor controlling the biology of fishes; (ii) no published data are available on the swimming performance, metabolic capacity or cardiac function of any of the ~165 grouper species worldwide; and (iii) the Nassau grouper is an endangered species of great ecological and socioeconomic significance in The Bahamas, we investigated how current summer/early fall (30°C) and winter (22°C) temperatures in South Eleuthera affected the aerobic metabolism and heart function of wild Nassau grouper when swum to exhaustion (i.e. to their critical swimming speed, Ucrit). The Nassau grouper had a very low Ucrit at 30°C (i.e. <1 body lengths s-1), and a 30% lower swimming performance during the winter (at 22°C), and this was that was indicative of a reduced absolute aerobic scope (~185 vs. 290 mg O2 kg-1 h-1) and values of maximum heart rate ([Formula: see text]HMax) and scope for [Formula: see text]H that were only one-half of that achieved at 30°C (~60 vs. 120 and 29 vs. 61 beats min-1, respectively). Overall, these data reveal that the Nassau grouper's aerobic and swimming capacity are well below values reported for other tropical/subtropical fishes and suggest that, despite a compensatory (~30-40%) increase in stroke volume, constraints on [Formula: see text]H near this species' lower thermal limit negatively affect its cardiac output and swimming performance. These findings have considerable ecological implications as Bahamian grouper populations migrate over long distances to spawn during the winter months, and given the predicted increase in temperature variability with climate change.

Acute and chronic cold exposure differentially affect cardiac control, but not cardiorespiratory function, in resting Atlantic salmon (Salmo salar).

No studies have examined the effects of cold temperatures (∼0-1 °C) on in vivo cardiac function and control, and metabolism, in salmonids. Thus, we examined: 1) how acclimation to 8 °C vs. acclimation (>3 weeks) or acute exposure (8-1 °C at 1 °C h-1) to 1 °C influenced cardiorespiratory parameters in resting Atlantic salmon; and 2) if/how the control of cardiac function was affected. Oxygen consumption ( M ˙ O 2 ) and cardiac function [i.e., heart rate (f H) and cardiac output ( Q ˙ ) ] were 50% lower in the acutely cooled and 1oC-acclimated salmon as compared to 8 °C fish, whereas stroke volume (VS) was unchanged. Intrinsic f H was not affected by whether the fish were acutely exposed or acclimated to 1 °C (values ∼51, 24 and 21 beats min-1 in 8 and 1 °C-acclimated fish, and 8-1 °C fish, respectively), and in all groups f H was primarily under adrenergic control/tone (cholinergic tone 13-18%; adrenergic tone 37-70%). However, ß-adrenergic blockade resulted in a 50% increase in VS in the 1oC-acclimated group, and this was surprising as circulating catecholamine levels were ∼1-3 nM in all groups. Overall, the data suggest that this species has a limited capacity to acclimate to temperatures approaching 0 °C. However, we cannot exclude the possibility that cardiac and metabolic responses are evoked when salmon are cooled to ∼ 0-1 °C, and that this prevented further declines in these parameters (i.e., they 'reset' quickly). Our data also provide further evidence that VS is temperature insensitive, and strongly suggest that changes in adrenoreceptor mediated control of venous pressure/capacitance occur when salmon are acclimated to 1 °C.

Design of synthetic hexapeptide substrates for prostate-specific antigen using single-position minilibraries.

Prostate-specific antigen (PSA), a serine endoprotease with chymotrypsin-like substrate specificity, is a marker used widely for detection of prostate cancer and other prostate diseases, catalyzing hydrolysis of the gel-forming proteins semenogelins I and II, which are synthesized and secreted by the seminal vesicle. In this study we report the use of two single-position minilibraries and RP-HPLC selection to optimize a hexapeptide substrate for PSA, spanning substrate positions P3 to P3'. PSA has been shown previously to prefer tyrosine in position P1 [Denmeade et al. (1997) Cancer Research, 57, 4924-4930]. Here we demonstrate preference for serine in position P1' and strong preference for phenylalanine in position P2. Based on these results we have designed and demonstrated the utility of the optimized fluorogenic PSA substrate 7-methoxy-coumarin-4-acetylGlnPheTyrSerSerAsnLys(epsilon-2,4-dinit rophenyl)amide, 1, which permits continuous monitoring of PSA endopeptidase activity at high sensitivity.

Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.

Elderly women are at increased risk for bone loss and fractures. In previous cross-sectional and longitudinal studies of women residing in northern latitudes, bone loss was most pronounced during winter months and in those consuming less than 1 g calcium per day. In this study we sought to test the hypothesis that calcium supplementation by either calcium carbonate or dietary means would prevent seasonal bone loss and preserve bone mass. Sixty older postmenopausal women without osteoporosis were randomized to one of three treatment arms: Dietary milk supplementation (D-4 glasses of milk/day), Calcium carbonate (CaCO3-1000 mg/day in two divided doses), or placebo (P). After 2 yr, placebo-treated women consumed a mean of 683 mg/day of calcium and lost 3.0% of their greater trochanteric (GT) bone mineral density (BMD) (P < 0.03 vs. baseline); Dietary supplemented women averaged a calcium intake of 1028 mg/day and sustained minimal loss from the GT (-1.5%; P = 0.30), whereas CaCO3-treated women (total Ca intake, 1633 mg/day) suffered no bone loss from the GT and showed a significant increase in spinal and femoral neck BMD (P < 0.05). Femoral bone loss occurred exclusively during the two winters of the study (i.e. total loss, -3.2%; P < 0.02 in placebo-treated women) with virtually no change in GT BMD during summer. Serum 25-OH vitamin D declined by more than 20% (P < 0.001) in all groups during the winter months but returned to baseline in summer; PTH levels rose approximately 20% (P < 0.001) during winter but did not return to baseline during the summers. Urine N-telopeptide and osteocalcin levels increased significantly but only in the P-treated women and only during winter. Serum insulin growth factor binding protein 4, an inhibitory insulin growth factor binding protein, rose 15% (P < 0.03) from summer to winter, but this increase was significant only in those women consuming <1000 mg/day of calcium. By multivariate analysis, total calcium intake was the strongest predictor of bone loss from the hip. Urinary N-telopeptide also closely correlated with GT BMD but only during winter (P = 0.003). We conclude that calcium supplementation prevents bone loss in elderly women by suppressing bone turnover during the winter when serum 25-OH vitamin D declines and serum PTH increases. The precise amount of calcium necessary to preserve BMD in elderly women requires further studies, although in this study, at least 1000 mg/day of supplemental calcium was adequate prophylaxis against femoral bone loss.

Preventing wading pool suction-drain injuries.

Wading pools with displaced drain covers and single drain outlets can lead to life-threatening injuries. This is a case of a Maryland child who sustained transanal suction which resulted in prolapse and avulsion of the small intestine from its blood supply. Because the injury would likely have been prevented if at least one of three safety precautions had been followed, standards for pool operation and pool design are reviewed.